Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
      • Neuroimmunology: To Sense and Protect
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons

User menu

  • Subscribe
  • Log in

Search

  • Advanced search
The Journal of Immunology
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons
  • Subscribe
  • Log in
The Journal of Immunology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Follow The Journal of Immunology on Twitter
  • Follow The Journal of Immunology on RSS

The IL-4 Receptor α-Chain-Binding Cytokines, IL-4 and IL-13, Induce Forkhead Box P3-Expressing CD25+CD4+ Regulatory T Cells from CD25−CD4+ Precursors

Alla Skapenko, Joachim R. Kalden, Peter E. Lipsky and Hendrik Schulze-Koops
J Immunol November 1, 2005, 175 (9) 6107-6116; DOI: https://doi.org/10.4049/jimmunol.175.9.6107
Alla Skapenko
*Nikolaus Fiebiger Center for Molecular Medicine, Clinical Research Group III, and
†Department of Internal Medicine III and Institute for Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joachim R. Kalden
†Department of Internal Medicine III and Institute for Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter E. Lipsky
‡National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD 20892
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hendrik Schulze-Koops
*Nikolaus Fiebiger Center for Molecular Medicine, Clinical Research Group III, and
†Department of Internal Medicine III and Institute for Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • FIGURE 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1.

    Development of anergic CD25+ Tregs in response to IL-4. Freshly isolated human naive CD4 T cells, either unfractionated or sorted into CD25+ and CD25− T cells where indicated, were cultured in the presence of autologous APC and in the presence or the absence of IL-4. After 10 days of culture, CD4 T cells were analyzed for the extent of expansion, as calculated by comparison of cell numbers before and after culture, for the surface expression of CD25, for the absolute number of CD25+ cells generated from an initial 1 × 106 CD4 T cells, and for the proliferative capacity of isolated CD25+ and CD25− T cells in response to anti-CD3. A, Representative staining patterns of freshly isolated naive CD4 T cells (pre) and naive CD4 T cells that had been cultured for 10 days in the absence or the presence of IL-4 are demonstrated. B, Expansion of CD4 T cells (a), the frequencies (b), and the absolute numbers (c) of recovered CD25+CD4 T cells before (pre) and after the 10-day cell culture in the presence or the absence of IL-4, and the proliferation of recovered CD25+ and CD25− cells in response to anti-CD3 (d) are shown. The results of nine independent experiments using cells from different donors (indicated by circles or as the mean ± SD) are summarized. C, Freshly isolated naive CD4 T cells were sorted into CD25− (sorted CD25−) and CD25+ (sorted CD25+) T cells or were left unfractionated (unseparated), and the proliferative and functional responses of these cells to IL-4 were examined. Data show the fold expansion of CD4 T cells (a), the frequencies (b) and the absolute numbers (c) of recovered CD25+CD4 T cells, and the proliferation of recovered CD25+ and CD25− cells in response to anti-CD3 (d). The results of nine independent experiments using cells from different donors (indicated by circles or as the mean ± SD) are shown. n.s., nonsignificant.

  • FIGURE 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2.

    Characterization of IL-4-generated CD25+ Tregs. Freshly isolated human naive CD4 T cells either unfractionated or depleted of CD25+ T cells where indicated were cultured in the presence of autologous APC and in the presence or the absence of IL-4. After 10 days of culture, CD4 T cells were sorted into CD25− and CD25+ T cells using a magnetic bead CD25+ cell depletion system. A, CD25+ and CD25− T cells isolated from IL-4-treated cultures of naive CD4 T cells either initially depleted of CD25+ cells (depleted) or unfractionated (unseparated) were analyzed for their proliferative capacity in response to anti-CD3 and for the expression of Foxp3 mRNA. The left panel demonstrates proliferation of 25 × 103 CD25− T cells in the absence or the presence of increasing numbers of CD25+ T cells in response to anti-CD3. The right panel shows Foxp3 mRNA expression by CD25+ and CD25− T cells relative to expression by CD25− T cells. The results of one representative experiment of six performed for proliferative capacity and five performed for Foxp3 mRNA levels are shown. B, Expression of CTLA-4 and GITR by CD25+ and CD25− T cells isolated from IL-4-treated cultures either directly after purification (nonactivated) or after 24-h stimulation with anti-CD3 (αCD3-activated). C, CD25+ and CD25− T cells isolated from cells cultured in the presence or the absence of IL-4 were stimulated with PMA/ionomycin for 24 h. Levels of IL-10, IL-4, IFN-γ, and TNF were determined in supernatants by ELISA. The results of 12 independent experiments using cells from different donors (demonstrated by circles) are shown. n.s., nonsignificant. D, The proliferative capacity of CD25+ and CD25− T cells isolated from cultures of IL-4-stimulated cells in response to anti-CD3 was assessed. The left panel shows inhibition of the proliferation of CD25− T cells by CD25+ T cells in the presence of neutralizing Abs to IL-4, IL-10, and TGF-β. The right panel demonstrates proliferation of CD25− cells when CD25+ cells were kept in a Transwell. A representative experiment of five (left panel) and four (right panel) performed is shown.

  • FIGURE 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 3.

    Endogenously produced cytokines in the IL-4-induced differentiation of CD25+ Tregs. Freshly isolated human naive CD4 T cells were cultured in the presence of autologous APC, IL-4, and neutralizing Abs to TGF-β, IL-10, or IL-2 or the appropriate isotype-matched Abs. After 10 days of culture, CD4 T cells were analyzed for the extent of expansion, as calculated by comparison of cell numbers before and after the 10-day culture, for the frequency of CD25+ cells, for the absolute number of CD25+ cells generated from an initial 1 × 106 CD4 T cells, and for the proliferative capacity of CD25+ and CD25− T cells in response to anti-CD3. A, The effects of endogenous TGF-β and IL-10 on the expansion of CD4 T cells (a), the frequencies (b) and absolute numbers (c) of recovered CD25+CD4 T cells, and the proliferation of recovered CD25+ and CD25− cells isolated from cultured cells in response to anti-CD3 (d) were investigated by addition of neutralizing anti-TGF-β (αTGFβ), anti-IL-10 (αIL-10) or isotype-matched (IgG2b) Abs. The results of seven independent experiments using cells from different donors (demonstrated by circles or as the mean ± SD) are shown. B, The effects of endogenous IL-2 on the expansion of CD4 T cells (a), the frequencies (b) and the absolute numbers (c) of recovered CD25+CD4 T cells, and the proliferation of recovered CD25+ and CD25− cells isolated from cultured cells in response to anti-CD3 (d) were investigated by addition of neutralizing anti-IL-2 (αIL-2) or isotype-matched (IgG2a) Abs. The results of 14 independent experiments using cells from different donors (demonstrated by circles or as the mean ± SD) are shown. n.s., Nonsignificant.

  • FIGURE 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 4.

    Effect of Th2 cytokines on the induction of CD25+ Tregs. Freshly isolated human naive CD4 T cells were cultured in the presence of autologous APC and in the presence of IL-4, IL-5, IL-9, or IL-13. After 10 days of culture, CD4 T cells were analyzed for the extent of expansion, as calculated by comparison of the cell numbers before and after the culture (A), for the frequency (B) and the absolute numbers (C) of recovered CD25+ cells, and for the proliferative capacity of CD25+ and CD25− T cells isolated from cultured cells in response to anti-CD3 (D). The results of nine independent experiments using cells from different donors (demonstrated by circles or as the mean ± SD) are shown. n.s., Nonsignificant.

  • FIGURE 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 5.

    Analysis of the Ag specificity of IL-4-induced CD25+ Tregs. Freshly isolated human naive CD4 T cells were cultured for 10 days in the presence of autologous APC and in the presence or the absence of IL-4. A, The requirement for TCR and costimulatory signaling in the IL-4-mediated generation of CD25+ T cells was investigated by the addition of neutralizing anti-HLA-DR (αHLA-DR), CTLA-4-Ig (CTLA-4-Ig), or irrelevant mouse IgG2a (IgG2a). After 10 days of culture, CD4 T cells were analyzed for the extent of expansion, as calculated by comparison of cell numbers before and after culture (a), for the frequency of CD25+ cells (b), for the absolute numbers of CD25+ cells generated from an initial 1 × 106 CD4 T cells (c), and for the proliferative capacity of CD25+ and CD25− T cells isolated from cultured cells in response to anti-CD3 (d). The results of seven independent experiments using cells from different donors (demonstrated by circles or as the mean ± SD) are shown. n.s., nonsignificant. B, The Ag specificity of IL-4-induced CD25+ Tregs was tested by assessing the proliferative capacity of CD25+ T cells generated in the absence of IL-4 (CD25+ no IL-4) and the presence of IL-4 (CD25+ IL-4) in response to autologous (auto DC) or allogeneic (allo DC) irradiated DC, alone or in coculture. The results of one representative experiment performed in triplicate of 11 independent experiments using cells from different donors are shown.

  • FIGURE 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 6.

    Effects of IL-4 and IL-13 on CD25+ Tregs in response to oral Ag administration. OVA TCR-Tg mice were fed OVA in the drinking water for 5 days, and splenocytes were analyzed by flow cytometry on day 6. Where indicated, the animals were treated. A, Frequencies of total CD25+ T cells in CD4 T cells and CD4 T cells in the lymphocyte gate were analyzed. a, A representative expression pattern of CD25 by CD4 T cells isolated from unfed or OVA-fed mice is demonstrated. b, Mean ± SD percentage of CD25+ T cells within the CD4 population and of CD4 T cells within lymphocytes in unfed and OVA-fed mice. The data shown are the results of one of two independent experiments (five mice per group) with similar results. B, Animals were treated with Abs neutralizing IL-4 (αIL-4) or IL-13 (αIL-13) alone, with the combination of both (αIL-4/13), or, as a control, with complete rat IgG (rat IgG), as described in Materials and Methods, and the frequencies (a) and absolute numbers in the spleen (b) of clonotype-specific KJ1-26+CD25+CD4 T cells were investigated. The data shown are the results of one of two independent experiments (five mice per group) with similar results.

PreviousNext
Back to top

In this issue

The Journal of Immunology: 175 (9)
The Journal of Immunology
Vol. 175, Issue 9
1 Nov 2005
  • Table of Contents
  • About the Cover
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Immunology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The IL-4 Receptor α-Chain-Binding Cytokines, IL-4 and IL-13, Induce Forkhead Box P3-Expressing CD25+CD4+ Regulatory T Cells from CD25−CD4+ Precursors
(Your Name) has forwarded a page to you from The Journal of Immunology
(Your Name) thought you would like to see this page from the The Journal of Immunology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
The IL-4 Receptor α-Chain-Binding Cytokines, IL-4 and IL-13, Induce Forkhead Box P3-Expressing CD25+CD4+ Regulatory T Cells from CD25−CD4+ Precursors
Alla Skapenko, Joachim R. Kalden, Peter E. Lipsky, Hendrik Schulze-Koops
The Journal of Immunology November 1, 2005, 175 (9) 6107-6116; DOI: 10.4049/jimmunol.175.9.6107

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
The IL-4 Receptor α-Chain-Binding Cytokines, IL-4 and IL-13, Induce Forkhead Box P3-Expressing CD25+CD4+ Regulatory T Cells from CD25−CD4+ Precursors
Alla Skapenko, Joachim R. Kalden, Peter E. Lipsky, Hendrik Schulze-Koops
The Journal of Immunology November 1, 2005, 175 (9) 6107-6116; DOI: 10.4049/jimmunol.175.9.6107
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Disclosures
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Differential Susceptibility to Staphylococcal Superantigen (SsAg)-Induced Apoptosis of CD4+ T Cells from Atopic Dermatitis Patients and Healthy Subjects: The Inhibitory Effect of IL-4 on SsAg-Induced Apoptosis
  • HIV-1 Vaccination Administered Intramuscularly Can Induce Both Systemic and Mucosal T Cell Immunity in HIV-1-Uninfected Individuals
  • Osteopontin (Eta-1) and Fibroblast Growth Factor-2 Cross-Talk in Angiogenesis
Show more Clinical Immunology

Similar Articles

Navigate

  • Home
  • Current Issue
  • Next in The JI
  • Archive
  • Brief Reviews
  • Pillars of Immunology
  • Translating Immunology

For Authors

  • Submit a Manuscript
  • Instructions for Authors
  • About the Journal
  • Journal Policies
  • Editors

General Information

  • Advertisers
  • Subscribers
  • Rights and Permissions
  • Accessibility Statement
  • FAR 889
  • Privacy Policy
  • Disclaimer

Journal Services

  • Email Alerts
  • RSS Feeds
  • ImmunoCasts
  • Twitter

Copyright © 2021 by The American Association of Immunologists, Inc.

Print ISSN 0022-1767        Online ISSN 1550-6606